These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25560927)
1. Identification and characterization of ML352: a novel, noncompetitive inhibitor of the presynaptic choline transporter. Ennis EA; Wright J; Retzlaff CL; McManus OB; Lin Z; Huang X; Wu M; Li M; Daniels JS; Lindsley CW; Hopkins CR; Blakely RD ACS Chem Neurosci; 2015 Mar; 6(3):417-27. PubMed ID: 25560927 [TBL] [Abstract][Full Text] [Related]
2. Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compound. Bertron JL; Ennis EA; Tarr CJ; Wright J; Dickerson JW; Locuson CW; Blobaum AL; Rook JM; Blakely RD; Lindsley CW Bioorg Med Chem Lett; 2016 Oct; 26(19):4637-4640. PubMed ID: 27575469 [TBL] [Abstract][Full Text] [Related]
3. Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance. Holmstrand EC; Lund D; Cherian AK; Wright J; Martin RF; Ennis EA; Stanwood GD; Sarter M; Blakely RD Neurochem Int; 2014 Jul; 73():217-28. PubMed ID: 24274995 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the high-affinity choline transporter activity and trafficking by its association with cholesterol-rich lipid rafts. Cuddy LK; Winick-Ng W; Rylett RJ J Neurochem; 2014 Mar; 128(5):725-40. PubMed ID: 24127780 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice. Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138 [TBL] [Abstract][Full Text] [Related]
6. Activity and subcellular trafficking of the sodium-coupled choline transporter CHT is regulated acutely by peroxynitrite. Pinthong M; Black SA; Ribeiro FM; Pholpramool C; Ferguson SS; Rylett RJ Mol Pharmacol; 2008 Mar; 73(3):801-12. PubMed ID: 17971421 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporter. Bollinger SR; Engers DW; Ennis EA; Wright J; Locuson CW; Lindsley CW; Blakely RD; Hopkins CR Bioorg Med Chem Lett; 2015 Apr; 25(8):1757-1760. PubMed ID: 25801932 [TBL] [Abstract][Full Text] [Related]
8. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Ferguson SM; Bazalakova M; Savchenko V; Tapia JC; Wright J; Blakely RD Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8762-7. PubMed ID: 15173594 [TBL] [Abstract][Full Text] [Related]
9. Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake. Ruggiero AM; Wright J; Ferguson SM; Lewis M; Emerson KS; Iwamoto H; Ivy MT; Holmstrand EC; Ennis EA; Weaver CD; Blakely RD ACS Chem Neurosci; 2012 Oct; 3(10):767-81. PubMed ID: 23077721 [TBL] [Abstract][Full Text] [Related]
10. Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity. Koshy Cherian A; Parikh V; Wu Q; Mao-Draayer Y; Wang Q; Blakely RD; Sarter M Neurochem Int; 2017 Sep; 108():410-416. PubMed ID: 28577989 [TBL] [Abstract][Full Text] [Related]
11. Choline on the Move: Perspectives on the Molecular Physiology and Pharmacology of the Presynaptic Choline Transporter. Ennis EA; Blakely RD Adv Pharmacol; 2016; 76():175-213. PubMed ID: 27288078 [TBL] [Abstract][Full Text] [Related]
12. Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. Gates J; Ferguson SM; Blakely RD; Apparsundaram S J Pharmacol Exp Ther; 2004 Aug; 310(2):536-45. PubMed ID: 15064333 [TBL] [Abstract][Full Text] [Related]
14. Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. Parikh V; Sarter M J Neurochem; 2006 Apr; 97(2):488-503. PubMed ID: 16539662 [TBL] [Abstract][Full Text] [Related]
15. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. Ferguson SM; Savchenko V; Apparsundaram S; Zwick M; Wright J; Heilman CJ; Yi H; Levey AI; Blakely RD J Neurosci; 2003 Oct; 23(30):9697-709. PubMed ID: 14585997 [TBL] [Abstract][Full Text] [Related]
16. The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Bazalakova MH; Blakely RD Handb Exp Pharmacol; 2006; (175):525-44. PubMed ID: 16722248 [TBL] [Abstract][Full Text] [Related]
17. Modulation of high-affinity choline carrier activity following incubation of rat hippocampal synaptosomes with hemicholinium-3. Rylett RJ; Davis W; Walters SA Brain Res; 1993 Oct; 626(1-2):184-9. PubMed ID: 8281429 [TBL] [Abstract][Full Text] [Related]
18. Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy. Inazu M; Yamada T; Kubota N; Yamanaka T Pharmacol Res; 2013 Oct; 76():119-31. PubMed ID: 23948665 [TBL] [Abstract][Full Text] [Related]
19. The choline transporter resurfaces: new roles for synaptic vesicles? Ferguson SM; Blakely RD Mol Interv; 2004 Feb; 4(1):22-37. PubMed ID: 14993474 [TBL] [Abstract][Full Text] [Related]
20. Binding of [3H]hemicholinium-3 to the high-affinity choline transporter in electric organ synaptosomal membranes. O'Regan S J Neurochem; 1988 Dec; 51(6):1682-8. PubMed ID: 3183657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]